+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Artificial Intelligence in Biomedical Market by Components (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Application, End-Users - Forecast 2024-2030- Product Image
Global Artificial Intelligence in Biomedical Market by Components (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Application, End-Users - Forecast 2024-2030- Product Image
Sale

Global Artificial Intelligence in Biomedical Market by Components (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Application, End-Users - Forecast 2024-2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5896297
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Intelligence in Biomedical Market size was estimated at USD 4.70 billion in 2023, USD 5.78 billion in 2024, and is expected to grow at a CAGR of 24.18% to reach USD 21.40 billion by 2030.

Artificial intelligence (AI) in the biomedical market refers to the application of machine learning algorithms, natural language processing, and computer vision techniques on large datasets generated by the biomedical sector. The increasing demand for personalized medicine necessitates advanced data analysis through AI for optimizing drug efficacy and reducing side effects. Rapid advancements in high-throughput technologies have led to an exponential increase in genomics & proteomics, requiring AI-driven analytics for accurate interpretation. Governments worldwide are taking initiatives to promote big data analytics and precision medicine.

However, the high cost of implementing AI-powered biomedical solutions may adversely impact their use by the end-use sectors. Moreover, recent advancements in deep learning algorithms for predicting molecular interactions and ongoing research to expand applications of AI in biomedical are anticipated to propel the growth of artificial intelligence (AI) in the biomedical market globally.

Regional Insights

Artificial Intelligence (AI) in the biomedical market is evolving in the Americas owing to the well-established healthcare infrastructure, significant investments in AI-driven biomedical research, and the surge in the adoption of natural language processing (NLP) techniques. The European Union is also heavily investing in AI applications for biomedicine and emphasizing on developing advanced deep-learning techniques to aid in tissue engineering and regenerative medicine. In the Middle East and Africa, there is growing interest in harnessing AI for healthcare innovation to improve healthcare accessibility in resource-constrained settings.

The Asia-Pacific region, led by China, Japan, and India, is experiencing rapid AI adoption in the biomedical field with significant funding for AI-driven healthcare technologies and collaborations between academia and industry to develop innovative AI-powered healthcare solutions. Besides, cutting-edge patents and proliferating research activities are expected to enhance operational efficiency, encouraging their adoption by the end-use verticals globally.

Market Trends by Segment

  • Type: Significant penetration of AI-based biomedical software
  • Application: Extensive use in drug discovery & development
  • End-Users: Expanding applications of AI-based biomedical solutions in pharmaceutical companies

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Bionl.AI Launches Innovative Platform for No-Code Biomedical Research

Bionl.ai has recently introduced a new no-code platform for biomedical research, which harnesses the power of Artificial Intelligence. This platform offers a user-friendly interface, empowering researchers to construct and implement AI models in biomedicine swiftly. Its primary objective is to optimize the creation of AI models in biomedical research, thus enhancing efficiency and conserving valuable time and resources.

Epistemic AI launches biomedical GPT at BIO

Epistemic AI introduced GPT-Bio, a cutting-edge natural language generation technology specifically designed for the biomedical field. This advanced technology enables rapid comprehension of extensive biomedical information, facilitating the generation of actionable insights. GPT-Bio is anticipated to significantly expedite biomedical research and development efforts, contributing to breakthrough discoveries and advancements in the field.

NIH launches Bridge2AI program to expand the use of artificial intelligence in biomedical and behavioral research

The National Institute of Health (NIH) has launched the Bridge2AI program to promote using Artificial Intelligence (AI) in biomedical and behavioral research. This program funds initiatives that foster collaboration between technology developers and the biomedical research community. The overarching goal is to advance AI-driven solutions for complex healthcare challenges, including precision medicine, drug discovery, diagnostics, imaging analysis, and addressing health disparities.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Biomedical Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Arterys Inc., Aspen Technology Inc, Atomwise Inc, Augmedix, Inc., Behold.ai Technologies Limited, BenevolentAI SA, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Caption Health, Inc. by GE Healthcare, Cloud Pharmaceuticals, Inc., CloudMedX Inc., Corti ApS, Cyclica Inc, Deargen Inc, Deep Genomics Incorporated, Euretos Services BV, Exscientia plc, Google, LLC by Alphabet, Inc., Insilico Medicine, Intel Corporation, International Business Machines Corporation, InveniAI LLC, Isomorphic Labs, Novo Nordisk A/S, Sanofi SA, Turbine Ltd., Viseven Europe OU, and XtalPi Inc.

This research report offers invaluable insights into various crucial aspects of the Artificial Intelligence in Biomedical Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing digitalization and research in the biomedical sector worldwide
5.1.1.2. Surge in drug discovery & development activities
5.1.1.3. Rising demand for personalized and customized medicine
5.1.2. Restraints
5.1.2.1. High cost associated with AI in biomedical
5.1.3. Opportunities
5.1.3.1. Technological advancements in AI in biomedical solutions
5.1.3.2. Favorable investment landscape for the development of AI in biomedical solutions
5.1.4. Challenges
5.1.4.1. Concerns associated with data privacy and security
5.2. Market Segmentation Analysis
5.2.1. Type: Significant penetration of AI-based biomedical software
5.2.2. Application: Extensive use in drug discovery & development
5.2.3. End-Users: Expanding applications of AI-based biomedical solutions in pharmaceutical companies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Artificial Intelligence in Biomedical Market, by Components
6.1. Introduction
6.2. Hardware
6.3. Services
6.4. Software
7. Artificial Intelligence in Biomedical Market, by Technology
7.1. Introduction
7.2. Computer Vision
7.3. Context-Aware Computing
7.4. Machine Learning
7.5. Natural Language Processing
7.6. Querying Method
8. Artificial Intelligence in Biomedical Market, by Application
8.1. Introduction
8.2. Clinical Decision Support
8.3. Clinical Trial Coordinators & Investigators
8.4. Drug Discovery & Development
8.5. Genomics & Personalized Medicine
8.6. Medical Imaging & Radiology
9. Artificial Intelligence in Biomedical Market, by End-Users
9.1. Introduction
9.2. Biotechnology Firms
9.3. Hospitals & Diagnostic Centers
9.4. Pharmaceutical Companies
9.5. Research Institutions
10. Americas Artificial Intelligence in Biomedical Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Artificial Intelligence in Biomedical Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Artificial Intelligence in Biomedical Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Bionl.AI Launches Innovative Platform for No-Code Biomedical Research
13.3.2. Epistemic AI launches biomedical GPT at BIO
13.3.3. NIH launches Bridge2AI program to expand the use of artificial intelligence in biomedical and behavioral research
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET RESEARCH PROCESS
FIGURE 2. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET DYNAMICS
FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2023 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY QUERYING METHOD, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY QUERYING METHOD, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL DECISION SUPPORT, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL TRIAL COORDINATORS & INVESTIGATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY CLINICAL TRIAL COORDINATORS & INVESTIGATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MEDICAL IMAGING & RADIOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY MEDICAL IMAGING & RADIOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 75. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 76. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 77. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 78. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 79. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 80. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 81. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 82. CANADA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 83. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 84. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 85. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 86. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 87. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 90. MEXICO ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 119. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 120. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 121. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 122. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 123. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 126. CHINA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 127. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 128. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 129. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 130. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 131. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 134. INDIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 143. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 144. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 145. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 146. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 147. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 150. JAPAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 191. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 192. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 193. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 194. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 195. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 198. THAILAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 217. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 218. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 219. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 220. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 221. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 224. DENMARK ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 225. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 226. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 227. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 228. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 229. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 232. EGYPT ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 233. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 234. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 235. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 236. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 237. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 240. FINLAND ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 241. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 242. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 243. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 244. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 245. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 248. FRANCE ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 249. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 250. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 251. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 252. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 253. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 256. GERMANY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 265. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 266. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 267. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 268. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 269. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 272. ITALY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
TABLE 289. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2018-2023 (USD MILLION)
TABLE 290. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY COMPONENTS, 2024-2030 (USD MILLION)
TABLE 291. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
TABLE 292. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
TABLE 293. NORWAY ARTIFICIAL INTELLIGENCE IN BIOMEDICAL MARKET SIZE, BY APPLICATION, 2018-20

Companies Mentioned

  • AiCure, LLC
  • Arterys Inc.
  • Aspen Technology Inc
  • Atomwise Inc
  • Augmedix, Inc.
  • Behold.ai Technologies Limited
  • BenevolentAI SA
  • BioSymetrics Inc.
  • BPGbio Inc.
  • Butterfly Network, Inc.
  • Caption Health, Inc. by GE Healthcare
  • Cloud Pharmaceuticals, Inc.
  • CloudMedX Inc.
  • Corti ApS
  • Cyclica Inc
  • Deargen Inc
  • Deep Genomics Incorporated
  • Euretos Services BV
  • Exscientia plc
  • Google, LLC by Alphabet, Inc.
  • Insilico Medicine
  • Intel Corporation
  • International Business Machines Corporation
  • InveniAI LLC
  • Isomorphic Labs
  • Novo Nordisk A/S
  • Sanofi SA
  • Turbine Ltd.
  • Viseven Europe OU
  • XtalPi Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.78 Billion
Forecasted Market Value ( USD ) by 2030 $ 21.4 Billion
Compound Annual Growth Rate24.1%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Artificial Intelligence (AI) - Global Strategic Business Report - Product Image

Artificial Intelligence (AI) - Global Strategic Business Report

  • Report
  • 1222 Pages
  • Global
From
United States Artificial Intelligence Market, Competition, Forecast & Opportunities, 2028 - Product Image

United States Artificial Intelligence Market, Competition, Forecast & Opportunities, 2028

  • Report
  • 89 Pages
  • United States
From
Artificial Intelligence Systems Spending Global Market Report 2024 - Product Image

Artificial Intelligence Systems Spending Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Artificial Intelligence in Pharmaceutical Market by Offering (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Applications, End-users - Forecast 2024-2030 - Product Image

Global Artificial Intelligence in Pharmaceutical Market by Offering (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Applications, End-users - Forecast 2024-2030

  • Report
  • 199 Pages
  • Global
From
Global Artificial Intelligence in Manufacturing Market by Technology (Deep Learning, Machine Learning Platforms, Machine Vision), Application (Cybersecurity, Field Services, Industrial Robots), End-User - Forecast 2024-2030 - Product Image

Global Artificial Intelligence in Manufacturing Market by Technology (Deep Learning, Machine Learning Platforms, Machine Vision), Application (Cybersecurity, Field Services, Industrial Robots), End-User - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.